Ruthigen (RTGN) Posts Quarterly Results
Ruthigen (NASDAQ:RTGN) issued its quarterly earnings data on Monday. The company reported ($0.46) earnings per share (EPS) for the quarter, Stock Ratings Network reports.
Ruthigen (NASDAQ:RTGN) traded down 4.47% during mid-day trading on Monday, hitting $5.99. The stock had a trading volume of 32,136 shares. Ruthigen has a 52 week low of $5.75 and a 52 week high of $8.47. The stock has a 50-day moving average of $6.4 and a 200-day moving average of $6.64. The company’s market cap is $27.9 million.
On a related note, analysts at Dawson James initiated coverage on shares of Ruthigen in a research note on Wednesday, June 25th. They set a “buy” rating and a $12.00 price target on the stock.
Ruthigen, Inc, is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid (NASDAQ:RTGN), based therapeutics designed to prevent and treat infection in invasive applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.